1993
DOI: 10.1128/aac.37.1.142
|View full text |Cite
|
Sign up to set email alerts
|

Candidicidal activity of the human recombinant myeloperoxidase system

Abstract: The effect of the human recombinant myeloperoxidase (recMPO) system on the viability of Candida albicans blastospores was determined. Cells were incubated in the presence of the enzyme, H202, and various substrates. In optimal conditions, 100% mortality was reached with only 41 mU of recMPO per ml, confirming its powerful candidicidal activity.To fight invading microorganisms, polymorphonuclear neutrophils use essentially two mechanisms. The first one, which is nonoxidative, involves such molecules as defensin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1996
1996
2010
2010

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 13 publications
(10 reference statements)
0
2
0
Order By: Relevance
“…However, exogenous MPO appeared to transiently increase vaginal MPO levels, suggesting that, at least for a brief period of time, this method of augmentation of endogenous vaginal defenses might be effective. If MPO works in synergy with vaginal H 2 O 2 -producing organisms, then a similar protective effect against STD, as has been seen in 6itro, may occur in 6i6o [2,5,7,13,15]. This effect remains to be adequately tested in this or another suitable model.…”
Section: Discussionmentioning
confidence: 87%
See 1 more Smart Citation
“…However, exogenous MPO appeared to transiently increase vaginal MPO levels, suggesting that, at least for a brief period of time, this method of augmentation of endogenous vaginal defenses might be effective. If MPO works in synergy with vaginal H 2 O 2 -producing organisms, then a similar protective effect against STD, as has been seen in 6itro, may occur in 6i6o [2,5,7,13,15]. This effect remains to be adequately tested in this or another suitable model.…”
Section: Discussionmentioning
confidence: 87%
“…Following sample collection at time 0, the five animals randomly selected for MPO treatment received a vaginal infusion of 1.5 ml of sterile lubricant (KY gel, nonbacteriostatic; Johnson & Johnson Corp., new Brunswick, New Jersey) mixed with 250 mg of recombinant MPO. Recombinant MPO, which has been shown to be microbicidal [2,13], was generously provided by N. Moguilevsky and A. Bollen of the Service de Génétique Appliquée, Université Libre de Bruxelles, Belgium. Sample collection was repeated at 4 and 24 hours.…”
Section: Methodsmentioning
confidence: 99%